Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

Visentin A, Cellini A, Rossi A, Patti C, Picardi M, Romano A, Guidetti A, Zizzari A, Oppi S, Bolis S, Gini G, Battistini R, Sorasio R, Rapezzi D, Vitale C, Bernardelli A, Schiavotto C, Cavallari M, Flenghi L, Ferreri AJ, Miglino M, Cimminiello M, Frolli A, Rosanelli C, Chiaravalloti A, Gregianin M, Fallanca F, Chauvie S, Pavoni C, Gianni AM, Tarella C, Viviani S, Trentin L, Rambaldi A, Gallamini A

Open source

DOI
10.1016/j.eclinm.2026.104063
Published
2026 Aug
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104063,
  title = {Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.},
  author = {Visentin A and Cellini A and Rossi A and Patti C and Picardi M and Romano A and Guidetti A and Zizzari A and Oppi S and Bolis S and Gini G and Battistini R and Sorasio R and Rapezzi D and Vitale C and Bernardelli A and Schiavotto C and Cavallari M and Flenghi L and Ferreri AJ and Miglino M and Cimminiello M and Frolli A and Rosanelli C and Chiaravalloti A and Gregianin M and Fallanca F and Chauvie S and Pavoni C and Gianni AM and Tarella C and Viviani S and Trentin L and Rambaldi A and Gallamini A},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104063},
  url = {https://doi.org/10.1016/j.eclinm.2026.104063}
}

RIS

TY  - JOUR
TI  - Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.
AU  - Visentin A
AU  - Cellini A
AU  - Rossi A
AU  - Patti C
AU  - Picardi M
AU  - Romano A
AU  - Guidetti A
AU  - Zizzari A
AU  - Oppi S
AU  - Bolis S
AU  - Gini G
AU  - Battistini R
AU  - Sorasio R
AU  - Rapezzi D
AU  - Vitale C
AU  - Bernardelli A
AU  - Schiavotto C
AU  - Cavallari M
AU  - Flenghi L
AU  - Ferreri AJ
AU  - Miglino M
AU  - Cimminiello M
AU  - Frolli A
AU  - Rosanelli C
AU  - Chiaravalloti A
AU  - Gregianin M
AU  - Fallanca F
AU  - Chauvie S
AU  - Pavoni C
AU  - Gianni AM
AU  - Tarella C
AU  - Viviani S
AU  - Trentin L
AU  - Rambaldi A
AU  - Gallamini A
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104063
UR  - https://doi.org/10.1016/j.eclinm.2026.104063
ER  - 

APA

A, V., A, C., A, R., C, P., M, P., A, R., A, G., A, Z., S, O., S, B., G, G., R, B., R, S., D, R., C, V., A, B., C, S., M, C., L, F., AJ, F., M, M., M, C., A, F., C, R., A, C., M, G., F, F., S, C., C, P., AM, G., C, T., S, V., L, T., A, R., & A, G. (2026). Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104063

Source records